Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limb-Girdle Muscular Dystrophy, Type 2B (Miyoshi Myopathy, Dysferlin Deficiency)”

2 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 2 of 2 results

Early research (Phase 1)Study completedNCT02710500
What this trial is testing

RAAVrh74.MHCK7.DYSF.DV for Treatment of Dysferlinopathies

Who this might be right for
Dysferlinopathy
Sarepta Therapeutics, Inc. 2
Not applicableStudy completedNCT00893334
What this trial is testing

Evaluation of Limb-Girdle Muscular Dystrophy

Who this might be right for
Becker Muscular DystrophyLimb-Girdle Muscular Dystrophy, Type 2A (Calpain-3 Deficiency)Limb-Girdle Muscular Dystrophy, Type 2B (Miyoshi Myopathy, Dysferlin Deficiency)+1 more
Cooperative International Neuromuscular Research Group 60